A PIN1 polymorphism that prevents its suppression by AP4 associates with delayed onset of Alzheimer's disease
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Alzheimer’s disease (AD), the most common form of dementia, is characterized by the presence of neurofibrillary tangles composed of tau and senile plaques of amyloid-beta peptides (Aβ) derived from amyloid precursor protein (APP). Pin1 is a unique prolyl isomerase that has been shown to protect against age-dependent neurodegeneration by acting on phosphorylated tau and APP to suppress tangle formation and amyloidogenic APP processing. Here we report a functional polymorphism, rs2287839, in the Pin1 promoter that is significantly associated with a 3-year delay in the average age-at-onset (AAO) of late-onset AD in a Chinese population. More significantly, the Pin1 polymorphism rs2287839 is located within the consensus binding motif for the brain-selective transcription factor, AP4 (CAGCTG) and almost completely abolishes the ability of AP4 to bind and suppress the Pin1 promoter, as shown by chromatin immunoprecipitation, electrophoretic mobility shift assay and promoter luciferase assay. Moreover, overexpression or knockdown of AP4 resulted in an 80% reduction or two-fold increase in endogenous Pin1 levels, respectively. Thus, AP4 is a novel transcriptional repressor of Pin1 expression and the Pin1 promoter SNP identified in this study that prevents such suppression is associated with delayed onset of AD. These results indicate that regulation of Pin1 by AP4 plays a critical role in determining AAO of AD and might be a novel therapeutic target to delay the onset of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
Evans, D. A. (1989) · JAMA · doi:10.1001/jama.1989.03430180093036 · Cited by 1,226
The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease
Rogaeva, E., Meng, Y., Lee, J. H., Gu, Y., Kawarai, T., Zou, F., Katayama, T., Baldwin, C. T., Cheng, R., Hasegawa, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1943 · Cited by 1,167
The effects of human population structure on large genetic association studies
Marchini, J., Cardon, L. R., Phillips, M. S., & Donnelly, P. (2004) · Nature Genetics · doi:10.1038/ng1337 · Cited by 869 · cited 2×
“It has been shown that Chinese and Japanese subpopulations are more homogeneous and have a lower degree of population admixture (Marchini et al. 2004).”
BackgroundResultThe prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein
Lu, P.-J., Wulf, G., Zhou, X. Z., Davies, P., & Lu, K. P. (1999) · Nature · doi:10.1038/21650 · Cited by 721
Self-citationBertram, L., Lange, C., Mullin, K., Parkinson, M., Hsiao, M., Hogan, M. F., Schjeide, B. M. M., Hooli, B., DiVito, J., Ionita, I., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.10.008 · Cited by 511 · cited 1×
“2007) and genome-wide association studies (GWAS) (Bertram et al. 2008; Harold et al. 2009; Lambert et al. 2009) were performed to identify the risk predisposition genes for the vast majority of sporadic AD.”
BackgroundThe prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-β production
Pastorino, L., Sun, A., Lu, P.-J., Zhou, X. Z., Balastik, M., Finn, G., Wulf, G., Lim, J., Li, S.-H., Li, X., et al. (2006) · Nature · doi:10.1038/nature04543 · Cited by 487 · cited 4×
“isomerization of pThr668-Pro which is important in regulating APP processing and Aβ production (Pastorino et al. 2006).”
BackgroundInfluentialSelf-citationAge at Onset in Two Common Neurodegenerative Diseases Is Genetically Controlled
Li, Y.-J., Scott, W. K., Hedges, D. J., Zhang, F., Gaskell, P. C., Nance, M. A., Watts, R. L., Hubble, J. P., Koller, W. C., Pahwa, R., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/339815 · Cited by 312
The Number of Trait Loci in Late-Onset Alzheimer Disease
Daw, E. W., Payami, H., Nemens, E. J., Nochlin, D., Bird, T. D., Schellenberg, G. D., & Wijsman, E. M. (2000) · The American Journal of Human Genetics · doi:10.1086/302710 · Cited by 295
Genome-wide association studies in Alzheimer’s disease
Bertram, L., & Tanzi, R. E. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp406 · Cited by 257
Research works printed but not linked: 52
- Bettens, 2010, Current status on Alzheimer disease molecular genetics: from past, to present, to future, Hum. Mol. Genet, 19, R4, 10.1093/hmg/ddq142 · DOI · Paper page
- Brookmeyer, 1998, Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset, Am. J. Public Health, 88, 1337, 10.2105/AJPH.88.9.1337 · DOI · Paper page
- Brouwers, 2008, Molecular genetics of Alzheimer's disease: an update, Ann. Med, 40, 562, 10.1080/07853890802186905 · DOI · Paper page
- Butler, 2009, Meta-analysis of linkage studies for Alzheimer's disease − a web resource, Neurobiol. Aging, 30, 1037, 10.1016/j.neurobiolaging.2009.03.013 · DOI
- Butterfield, 2006, Pin1 in Alzheimer's disease, J. Neurochem, 98, 1697, 10.1111/j.1471-4159.2006.03995.x · DOI · Paper page
- Cathcart, 2005, Cystatin C as a risk factor for Alzheimer disease, Neurology, 64, 755, 10.1212/01.WNL.0000151980.42337.44 · DOI · Paper page
- Chiu, 1994, Reliability and validity of the Cantonese version of the Mini-Mental State Examination − A preliminary study, J. Hong Kong Collège Psychiatr, 4, 25
- Corder, 1993, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science, 261, 921, 10.1126/science.8346443 · DOI · Paper page
- Cui, 1998, Exon-I is involved in positive as well as negative regulation of human angiotensinogen gene expression, Gene, 224, 97, 10.1016/S0378-1119(98)00512-5 · DOI
- Dickson, 2008, A genomic scan for age at onset of Alzheimer's disease in 437 families from the NIMH Genetic Initiative, Am. J. Med. Genet. B Neuropsychiatr. Genet, 147B, 784, 10.1002/ajmg.b.30689 · DOI
- Guerreiro, 2010, Genetic variability in CLU and its association with Alzheimer's disease, PLoS One, 5, e9510, 10.1371/journal.pone.0009510 · DOI · Paper page
- Han, 2010, The functional promoter polymorphism (−842G > C) in the PIN1 gene is associated with decreased risk of breast cancer in non-Hispanic white women 55 years and younger, Breast Cancer Res. Treat, 122, 243, 10.1007/s10549-009-0682-9 · DOI
- Heinemeyer, 1998, Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL, Nucleic Acids Res, 26, 362, 10.1093/nar/26.1.362 · DOI · Paper page
- Holmans, 2005, Genome screen for loci influencing age at onset and rate of decline in late onset Alzheimer's disease, Am. J. Med. Genet. B Neuropsychiatr. Genet, 135B, 24, 10.1002/ajmg.b.30114 · DOI · Paper page
- Hu, 1990, Transcription factor AP-four contains multiple dimerization domains that regulate dimer specificity, Genes Dev, 4, 1741, 10.1101/gad.4.10.1741 · DOI · Paper page
- Imai, 2006, Transcriptional repression of human immunodeficiency virus type 1 by AP-4, J. Biol. Chem, 281, 12495, 10.1074/jbc.M511773200 · DOI
- Jowett, 2004, Genetic variation in BEACON influences quantitative variation in metabolic syndrome-related phenotypes, Diabetes, 53, 2467, 10.2337/diabetes.53.9.2467 · DOI
- Jung, 2008, AP4 encodes a c-MYC-inducible repressor of p21, Proc. Natl. Acad. Sci. U. S. A., 105, 15046, 10.1073/pnas.0801773105 · DOI · Paper page
- Kamboh, 2006, Genetic association of ubiquilin with Alzheimer's disease and related quantitative measures, Mol. Psychiatry, 11, 273, 10.1038/sj.mp.4001775 · DOI
- Kim, 2006, A repressor complex, AP4 transcription factor and geminin, negatively regulates expression of target genes in nonneuronal cells, Proc. Natl. Acad. Sci. U. S. A, 103, 13074, 10.1073/pnas.0601915103 · DOI
- Kohnken, 2000, Detection of tau phosphorylated at threonine two hundred and thirty-one in cerebrospinal fluid of Alzheimer's disease patients, Neurosci. Lett, 287, 187, 10.1016/S0304-3940(00)01178-2 · DOI · Paper page
- Lambert, 2006, Association study of the PIN1 gene with Alzheimer's disease, Neurosci. Lett, 402, 259, 10.1016/j.neulet.2006.04.010 · DOI
- Lambert, 2009, Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease, Nat. Genet, 41, 1094, 10.1038/ng.439 · DOI · Paper page
- Lee, 2009, Essential role of Pin1 in the regulation of TRF1 stability and telomere maintenance, Nat. Cell Biol, 11, 97, 10.1038/ncb1818 · DOI
- Li, 2003, Glutathione S-transferase omega-one modifies age-at-onset of Alzheimer disease and Parkinson disease, Hum. Mol. Genet, 12, 3259, 10.1093/hmg/ddg357 · DOI · Paper page
- Lim, 2008, Pin1 has opposite effects on wild-type and P301L tau stability and tauopathy, J. Clin. Invest, 118, 1877
- Lim, 2005, Pinning down phosphorylated tau and tauopathies, Biochim. Biophys. Acta, 1739, 311, 10.1016/j.bbadis.2004.10.003 · DOI
- Liou, 2003, Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration, Nature, 424, 556, 10.1038/nature01832 · DOI · Paper page
- Lu, 2009, A novel functional variant (−842G > C) in the PIN1 promoter contributes to decreased risk of squamous cell carcinoma of the head and neck by diminishing the promoter activity, Carcinogenesis, 30, 1717, 10.1093/carcin/bgp171 · DOI
- Lu, 2004, Pinning down cell signaling, cancer and Alzheimer's disease, Trends Biochem. Sci, 29, 200, 10.1016/j.tibs.2004.02.002 · DOI · Paper page
- Lu, 2007, Prolyl cis-trans isomerization as a molecular timer, Nat. Chem. Biol, 3, 619, 10.1038/nchembio.2007.35 · DOI · Paper page
- Lu, 1996, A human peptidyl-prolyl isomerase essential for regulation of mitosis, Nature, 380, 544, 10.1038/380544a0 · DOI · Paper page
- Lu, 2007, The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease, Nat. Rev. Mol. Cell Biol, 8, 904, 10.1038/nrm2261 · DOI · Paper page
- Ma, 2005, The association between promoter polymorphism of the interleukin-10 gene and Alzheimer's disease, Neurobiol. Aging, 26, 1005, 10.1016/j.neurobiolaging.2004.08.010 · DOI
- Ma, 2009, Polymorphisms of the estrogen receptor alpha (ESR1) gene and the risk of Alzheimer's disease in a southern Chinese community, Int. Psychogeriatr, 21, 977, 10.1017/S1041610209990068 · DOI
- Ma, 2008, Association of prostaglandin-endoperoxide synthase2 (PTGS2) in polymorphisms and Alzheimer's disease in Chinese, Neurobiol. Aging, 29, 856, 10.1016/j.neurobiolaging.2006.12.011 · DOI
- Maudsley, 2006, Protein twists and turns in Alzheimer disease, Nat. Med, 12, 392, 10.1038/nm0406-392 · DOI
- Mermod, 1988, Enhancer binding factors AP-four and AP-1 act in concert to activate SV40 late transcription in vitro, Nature, 332, 557, 10.1038/332557a0 · DOI · Paper page
- Nowotny, 2007, Association studies between common variants in prolyl isomerase Pin1 and the risk for late-onset Alzheimer's disease, Neurosci. Lett, 419, 15, 10.1016/j.neulet.2007.03.071 · DOI
- Ranganathan, 1997, Structural and functional analysis of the mitotic rotamase Pin1 suggests substrate recognition is phosphorylation dependent, Cell, 89, 875, 10.1016/S0092-8674(00)80273-1 · DOI · Paper page
- Ryo, 2002, PIN1 is an E2F target gene essential for Neu/Ras-induced transformation of mammary epithelial cells, Mol. Cell. Biol, 22, 5281, 10.1128/MCB.22.15.5281-5295.2002 · DOI · Paper page
- Sciacca, 2003, Interleukin-1B polymorphism is associated with age at onset of Alzheimer's disease, Neurobiol. Aging, 24, 927, 10.1016/S0197-4580(03)00011-3 · DOI
- Segat, 2007, PIN1 promoter polymorphisms are associated with Alzheimer's disease, Neurobiol. Aging, 28, 69, 10.1016/j.neurobiolaging.2005.11.009 · DOI
- Sultana, 2006, Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: A redox proteomics analysis, Neurobiol. Aging, 27, 918, 10.1016/j.neurobiolaging.2005.05.005 · DOI · Paper page
- Tang, 2006, Evaluation of an algorithm of tagging SNPs selection by linkage disequilibrium, Clin. Biochem, 39, 240, 10.1016/j.clinbiochem.2005.11.014 · DOI
- Waring, 2008, Genome-wide association studies in Alzheimer disease, Arch. Neurol, 65, 329, 10.1001/archneur.65.3.329 · DOI · Paper page
- Wijsman, 2004, Evidence for a novel late-onset Alzheimer disease locus on chromosome 19p132, Am. J. Hum. Genet, 75, 398, 10.1086/423393 · DOI · Paper page
- Wulf, 2005, Phosphorylation-specific prolyl isomerization: is there an underlying theme?, Nat. Cell Biol, 7, 435, 10.1038/ncb0505-435 · DOI · Paper page
- Yaffe, 1997, Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism, Science, 278, 1957, 10.1126/science.278.5345.1957 · DOI · Paper page
- Yap, 2003, Adaptor protein complex 4 (AP-4) is expressed in the central nervous system neurons and interacts with glutamate receptor delta2, Mol. Cell. Neurosci, 24, 283, 10.1016/S1044-7431(03)00164-7 · DOI
- Zhou, 2000, Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins, Mol. Cell, 6, 873, 10.1016/S1097-2765(05)00083-3 · doi:10.1016/s1097-2765(05)00083-3 · Paper page
- Zhou, 1999, Phosphorylation-dependent prolyl isomerization: a novel signaling regulatory mechanism, Cell. Mol. Life Sci, 56, 788, 10.1007/s000180050026 · DOI
Cited by
Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy
Kondo, A., Shahpasand, K., Mannix, R., Qiu, J., Moncaster, J., Chen, C.-H., Yao, Y., Lin, Y.-M., Driver, J. A., Sun, Y., et al. (2015) · Nature · doi:10.1038/nature14658 · Cited by 445
Self-citationProlyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins
Liou, Y.-C., Zhou, X. Z., & Lu, K. P. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.07.001 · Cited by 326
Self-citationThe isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target
Zhou, X. Z., & Lu, K. P. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.49 · Cited by 266
Self-citationNakamura, K., Greenwood, A., Binder, L., Bigio, E. H., Denial, S., Nicholson, L., Zhou, X. Z., & Lu, K. P. (2012) · Cell · doi:10.1016/j.cell.2012.02.016 · Cited by 258
Self-citationOspina-Romero, M., Glymour, M. M., Hayes-Larson, E., Mayeda, E. R., Graff, R. E., Brenowitz, W. D., Ackley, S. F., Witte, J. S., & Kobayashi, L. C. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.25515 · Cited by 124
Metadata
- Authors
- Ma, S. L., Tang, N. L. S., Tam, C. W. C., Lui, V. W. C., Lam, L. C. W., Chiu, H. F. K., Driver, J. A., Pastorino, L., & Lu, K. P.
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2012-04
- Volume
- 33
- Issue
- 4
- Pages
- 804-813
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W2073109388
- Cited by
- 74
- References
- 11
- FWCI
- 2.85
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Funders
- NIH (R01AG017870, R01GM058556)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A PIN1 polymorphism that prevents its suppression by AP4 associates with delayed onset of Alzheimer's disease. https://app.cochat.ai/papers/10.1016/j.neurobiolaging.2010.05.018
- The paper
- Ma, S. L., Tang, N. L. S., Tam, C. W. C., Lui, V. W. C., Lam, L. C. W., Chiu, H. F. K., Driver, J. A., Pastorino, L., & Lu, K. P. (2012). A PIN1 polymorphism that prevents its suppression by AP4 associates with delayed onset of Alzheimer's disease. Neurobiology of Aging. https://doi.org/10.1016/j.neurobiolaging.2010.05.018
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.